| 1 | serum | 46,955 |
| 2 | intramyocellular | 58 |
| 3 | nt-pro | 32 |
| 4 | intraplatelet | 22 |
| 5 | carbohydrate-deficient | 21 |
| 6 | uncarboxylated | 19 |
| 7 | preapheresis | 17 |
| 8 | plasma/serum | 16 |
| 9 | monophosphoryl | 15 |
| 10 | hdl/high | 10 |
| 11 | on-statin | 10 |
| 12 | transcardiac | 10 |
| 13 | amerlex-mab | 9 |
| 14 | ischemia-modified | 9 |
| 15 | amoxicillin/ | 7 |
| 16 | dialysate-to-plasma | 7 |
| 17 | dipeptide-supplemented | 7 |
| 18 | dnnrsf | 7 |
| 19 | phnom | 7 |
| 20 | goal/normal | 6 |
| 21 | mg/total | 6 |
| 22 | microsemi | 6 |
| 23 | peak-stimulated | 6 |
| 24 | pentulose | 6 |
| 25 | ppd-stimulated | 6 |
| 26 | cholesterol/ | 5 |
| 27 | vldl-associated | 5 |
| 28 | bipolar-related | 4 |
| 29 | dialysate-plasma | 4 |
| 30 | emblic | 4 |
| 31 | htg/low | 4 |
| 32 | milking-induced | 4 |
| 33 | 1/serum | 3 |
| 34 | 400-ppb | 3 |
| 35 | an-gong-niu-huang | 3 |
| 36 | baculoviral | 3 |
| 37 | bio-accessible | 3 |
| 38 | calcium/ | 3 |
| 39 | elecsys® | 3 |
| 40 | follicular-fluid | 3 |
| 41 | intrapituitary | 3 |
| 42 | late-follicular-phase | 3 |
| 43 | ldl-c/ | 3 |
| 44 | low-serum | 3 |
| 45 | macroaggregated | 3 |
| 46 | plasma-soluble | 3 |
| 47 | rotaglide+ | 3 |
| 48 | serum/dietary | 3 |
| 49 | serum/hepatic | 3 |
| 50 | triglyceride/low | 3 |
| 51 | 11,443 | 2 |
| 52 | 3,4-dimethoxy | 2 |
| 53 | aapm | 2 |
| 54 | anti-merozoite | 2 |
| 55 | apoa-i-containing | 2 |
| 56 | caf-specific | 2 |
| 57 | crp-stratified | 2 |
| 58 | cse-evoked | 2 |
| 59 | dialysate-side | 2 |
| 60 | direct/and | 2 |
| 61 | friedewald-calculated | 2 |
| 62 | gm1-specific | 2 |
| 63 | goal/desirable | 2 |
| 64 | h-chain | 2 |
| 65 | hairpinless | 2 |
| 66 | hdl-paf-ah/ | 2 |
| 67 | hemosil | 2 |
| 68 | ischaemia-modified | 2 |
| 69 | kemtrace | 2 |
| 70 | lectin-bound | 2 |
| 71 | limit-2 | 2 |
| 72 | lipid-corrected | 2 |
| 73 | microm/mg | 2 |
| 74 | mrc/eortc | 2 |
| 75 | myristamidopropyl | 2 |
| 76 | non-ldl-c | 2 |
| 77 | oxldl/human | 2 |
| 78 | pa-specific | 2 |
| 79 | phytin | 2 |
| 80 | pl-plasma | 2 |
| 81 | plasma-conjugated | 2 |
| 82 | pre-/post-apheresis | 2 |
| 83 | segfr-dependent | 2 |
| 84 | slow-cooled | 2 |
| 85 | suhexiang | 2 |
| 86 | t4-off | 2 |
| 87 | tg/low | 2 |
| 88 | triglyceride-low | 2 |
| 89 | α-oligoglucosyl | 2 |
| 90 | δfree | 2 |
| 91 | δserum | 2 |
| 92 | ∆total | 2 |
| 93 | 'undetectable | 1 |
| 94 | *serum | 1 |
| 95 | -epoxy | 1 |
| 96 | /admission | 1 |
| 97 | 0.75-mg/kg | 1 |
| 98 | 1,1',2,2'-tetramyristoyl | 1 |
| 99 | 1,1,1,5,5,5-d6-diethyl | 1 |
| 100 | 1-alpha-hydroxy | 1 |
| 101 | 1-tertile | 1 |
| 102 | 10306 | 1 |
| 103 | 12/368 | 1 |
| 104 | 14122 | 1 |
| 105 | 18,491 | 1 |
| 106 | 2,052,534 | 1 |
| 107 | 2,2,4,4-d4-diethyl | 1 |
| 108 | 2,2-2,7 | 1 |
| 109 | 20,224 | 1 |
| 110 | 2010.a | 1 |
| 111 | 4,540 | 1 |
| 112 | 4-methacryloyloxyethyl | 1 |
| 113 | 40,544 | 1 |
| 114 | 4915 | 1 |
| 115 | 6,210 | 1 |
| 116 | 6,618,637 | 1 |
| 117 | 6141 | 1 |
| 118 | 67-kda | 1 |
| 119 | 9,072 | 1 |
| 120 | :3xflag | 1 |
| 121 | a20/an1-like | 1 |
| 122 | acyl/free | 1 |
| 123 | alpha-myhc | 1 |
| 124 | aluminum-co-doped | 1 |
| 125 | an1/a20-like | 1 |
| 126 | anti-als3p | 1 |
| 127 | anti-bcii | 1 |
| 128 | antioncogenic | 1 |
| 129 | ardenal | 1 |
| 130 | asparaginase-associated | 1 |
| 131 | avidin- | 1 |
| 132 | b-box | 1 |
| 133 | baseline-free | 1 |
| 134 | bde-47-stimulated | 1 |
| 135 | before-exercise | 1 |
| 136 | belleric | 1 |
| 137 | benzylamine-based | 1 |
| 138 | biman | 1 |
| 139 | bldod | 1 |
| 140 | blood/uric | 1 |
| 141 | buhlmann | 1 |
| 142 | c24:1-induced | 1 |
| 143 | c3hc4 | 1 |
| 144 | c5-sugars | 1 |
| 145 | cationized | 1 |
| 146 | cd31+cd42- | 1 |
| 147 | changesin | 1 |
| 148 | children.a | 1 |
| 149 | cll-like | 1 |
| 150 | cobalt- | 1 |
| 151 | collagen/urinary | 1 |
| 152 | creatinine-normalised | 1 |
| 153 | cys3his | 1 |
| 154 | cysteine-enriched | 1 |
| 155 | dehydration/elevated | 1 |
| 156 | density- | 1 |
| 157 | depression-infant | 1 |
| 158 | desipramine-stimulated | 1 |
| 159 | dialysis-to-plasma | 1 |
| 160 | diphosphoryl | 1 |
| 161 | dxa-determined | 1 |
| 162 | ef-cm-f1- | 1 |
| 163 | end-of-diet | 1 |
| 164 | faah-like | 1 |
| 165 | floraglo® | 1 |
| 166 | folate-mediated | 1 |
| 167 | fxr-dependent | 1 |
| 168 | gel-released | 1 |
| 169 | gianturco | 1 |
| 170 | glycerophospholipid-derived | 1 |
| 171 | gp-derived | 1 |
| 172 | hamd-5 | 1 |
| 173 | hdl-cholesterol/high | 1 |
| 174 | hdl-c±high | 1 |
| 175 | heme-scavenger | 1 |
| 176 | hepatic-borne | 1 |
| 177 | hexaacyl | 1 |
| 178 | high-hs | 1 |
| 179 | homocysteinylated | 1 |
| 180 | hpl-coated | 1 |
| 181 | huoxiangzhengqi | 1 |
| 182 | hydroxylysyl | 1 |
| 183 | hyper-uric | 1 |
| 184 | igf1/low | 1 |
| 185 | il-17/low | 1 |
| 186 | il-3/tnf-induced | 1 |
| 187 | immunization-linked | 1 |
| 188 | inner-to-outer | 1 |
| 189 | iodine-labeled | 1 |
| 190 | isovaleryl | 1 |
| 191 | isrctn42521357 | 1 |
| 192 | kidney-urine | 1 |
| 193 | kokkola | 1 |
| 194 | l-citrulline/ | 1 |
| 195 | lecithin/ | 1 |
| 196 | lectin-related | 1 |
| 197 | levobupivicaine.a | 1 |
| 198 | lic/serum | 1 |
| 199 | lipid-transporting | 1 |
| 200 | log-adjusted | 1 |
| 201 | lpa-i/total | 1 |
| 202 | lysophosphatidyl | 1 |
| 203 | m-hydroxy-p-methoxy | 1 |
| 204 | madrs/ham-d | 1 |
| 205 | male-noninduced | 1 |
| 206 | mau*min/μg | 1 |
| 207 | medication-adjusted | 1 |
| 208 | membrane/storage | 1 |
| 209 | micheal | 1 |
| 210 | mothers | 1 |
| 211 | mtbs-induced | 1 |
| 212 | myrosinase-dependent | 1 |
| 213 | n-alpha-tosyl-l-lysyl-chloromethyl | 1 |
| 214 | n-benzoylimino-3,4-dihydro-6-methylisoquinolinium | 1 |
| 215 | n-monomethyl | 1 |
| 216 | nematocide | 1 |
| 217 | neodymium-containing | 1 |
| 218 | neuroinhibitory/neuroprotective | 1 |
| 219 | neutropenia.when | 1 |
| 220 | ng-monomethyl- | 1 |
| 221 | nk-derived | 1 |
| 222 | non-allylic | 1 |
| 223 | non-hydrolysable | 1 |
| 224 | non-phytic | 1 |
| 225 | non-ribavirin-associated | 1 |
| 226 | nonenzymatic-induced | 1 |
| 227 | oa-stimulated | 1 |
| 228 | pai-1/ | 1 |
| 229 | papa-specific | 1 |
| 230 | per-follicle | 1 |
| 231 | peri-conceptual | 1 |
| 232 | pg/mmol | 1 |
| 233 | pgi-memory-scale | 1 |
| 234 | phosphatase-minus | 1 |
| 235 | phytate-bound | 1 |
| 236 | pin1-mediated | 1 |
| 237 | plasma/urinary | 1 |
| 238 | polyglecaprone | 1 |
| 239 | polysulphated | 1 |
| 240 | post-anticoagulation | 1 |
| 241 | post-proximal | 1 |
| 242 | post-right | 1 |
| 243 | postezetimibe | 1 |
| 244 | postmethionine | 1 |
| 245 | postsuckling | 1 |
| 246 | pratsiol-associated | 1 |
| 247 | pre-gh | 1 |
| 248 | ps-f2-stimulated | 1 |
| 249 | psg-1-indcued | 1 |
| 250 | ptnps-catalyzed | 1 |
| 251 | ptx3-neonatal | 1 |
| 252 | pyrazolocarbazole | 1 |
| 253 | quinine.a | 1 |
| 254 | ratio-iga-serum | 1 |
| 255 | retrospectively.in | 1 |
| 256 | rh- | 1 |
| 257 | rituximab-induced | 1 |
| 258 | rns-related | 1 |
| 259 | s-carboxy-methylated | 1 |
| 260 | sagrat | 1 |
| 261 | sall4/sox2/oct-3/4 | 1 |
| 262 | self-efficacy.a | 1 |
| 263 | serum-ascites | 1 |
| 264 | serum-screening | 1 |
| 265 | serum/adipose | 1 |
| 266 | situation.- | 1 |
| 267 | sphingolipid-derived | 1 |
| 268 | str/log | 1 |
| 269 | terpenylated | 1 |
| 270 | tetra-sodium | 1 |
| 271 | tgf-β1-treated | 1 |
| 272 | three-hundred-fifty-four | 1 |
| 273 | time-zero | 1 |
| 274 | toluenesulfonamide | 1 |
| 275 | transcranial-evoked | 1 |
| 276 | treatment-by-serum | 1 |
| 277 | tumour-produced | 1 |
| 278 | unrestrains | 1 |
| 279 | vitro-stimulated | 1 |
| 280 | xieqing | 1 |
| 281 | zakhire | 1 |
| 282 | zakhireh-i | 1 |
| 283 | zuoci | 1 |
| 284 | µmol/mmol | 1 |
| 285 | α-2,3-bound | 1 |
| 286 | α9-subunit-containing | 1 |
| 287 | β-2,5-furanoid | 1 |
| 288 | δhr/δlog | 1 |
| 1 | 'undetectable | 1 |
| 2 | *serum | 1 |
| 3 | -epoxy | 1 |
| 4 | /admission | 1 |
| 5 | 0.75-mg/kg | 1 |
| 6 | 1,1',2,2'-tetramyristoyl | 1 |
| 7 | 1,1,1,5,5,5-d6-diethyl | 1 |
| 8 | 1-alpha-hydroxy | 1 |
| 9 | 1-tertile | 1 |
| 10 | 1/serum | 3 |
| 11 | 10306 | 1 |
| 12 | 11,443 | 2 |
| 13 | 12/368 | 1 |
| 14 | 14122 | 1 |
| 15 | 18,491 | 1 |
| 16 | 2,052,534 | 1 |
| 17 | 2,2,4,4-d4-diethyl | 1 |
| 18 | 2,2-2,7 | 1 |
| 19 | 20,224 | 1 |
| 20 | 2010.a | 1 |
| 21 | 3,4-dimethoxy | 2 |
| 22 | 4,540 | 1 |
| 23 | 4-methacryloyloxyethyl | 1 |
| 24 | 40,544 | 1 |
| 25 | 400-ppb | 3 |
| 26 | 4915 | 1 |
| 27 | 6,210 | 1 |
| 28 | 6,618,637 | 1 |
| 29 | 6141 | 1 |
| 30 | 67-kda | 1 |
| 31 | 9,072 | 1 |
| 32 | :3xflag | 1 |
| 33 | a20/an1-like | 1 |
| 34 | aapm | 2 |
| 35 | acyl/free | 1 |
| 36 | alpha-myhc | 1 |
| 37 | aluminum-co-doped | 1 |
| 38 | amerlex-mab | 9 |
| 39 | amoxicillin/ | 7 |
| 40 | an-gong-niu-huang | 3 |
| 41 | an1/a20-like | 1 |
| 42 | anti-als3p | 1 |
| 43 | anti-bcii | 1 |
| 44 | anti-merozoite | 2 |
| 45 | antioncogenic | 1 |
| 46 | apoa-i-containing | 2 |
| 47 | ardenal | 1 |
| 48 | asparaginase-associated | 1 |
| 49 | avidin- | 1 |
| 50 | b-box | 1 |
| 51 | baculoviral | 3 |
| 52 | baseline-free | 1 |
| 53 | bde-47-stimulated | 1 |
| 54 | before-exercise | 1 |
| 55 | belleric | 1 |
| 56 | benzylamine-based | 1 |
| 57 | biman | 1 |
| 58 | bio-accessible | 3 |
| 59 | bipolar-related | 4 |
| 60 | bldod | 1 |
| 61 | blood/uric | 1 |
| 62 | buhlmann | 1 |
| 63 | c24:1-induced | 1 |
| 64 | c3hc4 | 1 |
| 65 | c5-sugars | 1 |
| 66 | caf-specific | 2 |
| 67 | calcium/ | 3 |
| 68 | carbohydrate-deficient | 21 |
| 69 | cationized | 1 |
| 70 | cd31+cd42- | 1 |
| 71 | changesin | 1 |
| 72 | children.a | 1 |
| 73 | cholesterol/ | 5 |
| 74 | cll-like | 1 |
| 75 | cobalt- | 1 |
| 76 | collagen/urinary | 1 |
| 77 | creatinine-normalised | 1 |
| 78 | crp-stratified | 2 |
| 79 | cse-evoked | 2 |
| 80 | cys3his | 1 |
| 81 | cysteine-enriched | 1 |
| 82 | dehydration/elevated | 1 |
| 83 | density- | 1 |
| 84 | depression-infant | 1 |
| 85 | desipramine-stimulated | 1 |
| 86 | dialysate-plasma | 4 |
| 87 | dialysate-side | 2 |
| 88 | dialysate-to-plasma | 7 |
| 89 | dialysis-to-plasma | 1 |
| 90 | dipeptide-supplemented | 7 |
| 91 | diphosphoryl | 1 |
| 92 | direct/and | 2 |
| 93 | dnnrsf | 7 |
| 94 | dxa-determined | 1 |
| 95 | ef-cm-f1- | 1 |
| 96 | elecsys® | 3 |
| 97 | emblic | 4 |
| 98 | end-of-diet | 1 |
| 99 | faah-like | 1 |
| 100 | floraglo® | 1 |
| 101 | folate-mediated | 1 |
| 102 | follicular-fluid | 3 |
| 103 | friedewald-calculated | 2 |
| 104 | fxr-dependent | 1 |
| 105 | gel-released | 1 |
| 106 | gianturco | 1 |
| 107 | glycerophospholipid-derived | 1 |
| 108 | gm1-specific | 2 |
| 109 | goal/desirable | 2 |
| 110 | goal/normal | 6 |
| 111 | gp-derived | 1 |
| 112 | h-chain | 2 |
| 113 | hairpinless | 2 |
| 114 | hamd-5 | 1 |
| 115 | hdl-cholesterol/high | 1 |
| 116 | hdl-c±high | 1 |
| 117 | hdl-paf-ah/ | 2 |
| 118 | hdl/high | 10 |
| 119 | heme-scavenger | 1 |
| 120 | hemosil | 2 |
| 121 | hepatic-borne | 1 |
| 122 | hexaacyl | 1 |
| 123 | high-hs | 1 |
| 124 | homocysteinylated | 1 |
| 125 | hpl-coated | 1 |
| 126 | htg/low | 4 |
| 127 | huoxiangzhengqi | 1 |
| 128 | hydroxylysyl | 1 |
| 129 | hyper-uric | 1 |
| 130 | igf1/low | 1 |
| 131 | il-17/low | 1 |
| 132 | il-3/tnf-induced | 1 |
| 133 | immunization-linked | 1 |
| 134 | inner-to-outer | 1 |
| 135 | intramyocellular | 58 |
| 136 | intrapituitary | 3 |
| 137 | intraplatelet | 22 |
| 138 | iodine-labeled | 1 |
| 139 | ischaemia-modified | 2 |
| 140 | ischemia-modified | 9 |
| 141 | isovaleryl | 1 |
| 142 | isrctn42521357 | 1 |
| 143 | kemtrace | 2 |
| 144 | kidney-urine | 1 |
| 145 | kokkola | 1 |
| 146 | l-citrulline/ | 1 |
| 147 | late-follicular-phase | 3 |
| 148 | ldl-c/ | 3 |
| 149 | lecithin/ | 1 |
| 150 | lectin-bound | 2 |
| 151 | lectin-related | 1 |
| 152 | levobupivicaine.a | 1 |
| 153 | lic/serum | 1 |
| 154 | limit-2 | 2 |
| 155 | lipid-corrected | 2 |
| 156 | lipid-transporting | 1 |
| 157 | log-adjusted | 1 |
| 158 | low-serum | 3 |
| 159 | lpa-i/total | 1 |
| 160 | lysophosphatidyl | 1 |
| 161 | m-hydroxy-p-methoxy | 1 |
| 162 | macroaggregated | 3 |
| 163 | madrs/ham-d | 1 |
| 164 | male-noninduced | 1 |
| 165 | mau*min/μg | 1 |
| 166 | medication-adjusted | 1 |
| 167 | membrane/storage | 1 |
| 168 | mg/total | 6 |
| 169 | micheal | 1 |
| 170 | microm/mg | 2 |
| 171 | microsemi | 6 |
| 172 | milking-induced | 4 |
| 173 | monophosphoryl | 15 |
| 174 | mothers | 1 |
| 175 | mrc/eortc | 2 |
| 176 | mtbs-induced | 1 |
| 177 | myristamidopropyl | 2 |
| 178 | myrosinase-dependent | 1 |
| 179 | n-alpha-tosyl-l-lysyl-chloromethyl | 1 |
| 180 | n-benzoylimino-3,4-dihydro-6-methylisoquinolinium | 1 |
| 181 | n-monomethyl | 1 |
| 182 | nematocide | 1 |
| 183 | neodymium-containing | 1 |
| 184 | neuroinhibitory/neuroprotective | 1 |
| 185 | neutropenia.when | 1 |
| 186 | ng-monomethyl- | 1 |
| 187 | nk-derived | 1 |
| 188 | non-allylic | 1 |
| 189 | non-hydrolysable | 1 |
| 190 | non-ldl-c | 2 |
| 191 | non-phytic | 1 |
| 192 | non-ribavirin-associated | 1 |
| 193 | nonenzymatic-induced | 1 |
| 194 | nt-pro | 32 |
| 195 | oa-stimulated | 1 |
| 196 | on-statin | 10 |
| 197 | oxldl/human | 2 |
| 198 | pa-specific | 2 |
| 199 | pai-1/ | 1 |
| 200 | papa-specific | 1 |
| 201 | peak-stimulated | 6 |
| 202 | pentulose | 6 |
| 203 | per-follicle | 1 |
| 204 | peri-conceptual | 1 |
| 205 | pg/mmol | 1 |
| 206 | pgi-memory-scale | 1 |
| 207 | phnom | 7 |
| 208 | phosphatase-minus | 1 |
| 209 | phytate-bound | 1 |
| 210 | phytin | 2 |
| 211 | pin1-mediated | 1 |
| 212 | pl-plasma | 2 |
| 213 | plasma-conjugated | 2 |
| 214 | plasma-soluble | 3 |
| 215 | plasma/serum | 16 |
| 216 | plasma/urinary | 1 |
| 217 | polyglecaprone | 1 |
| 218 | polysulphated | 1 |
| 219 | post-anticoagulation | 1 |
| 220 | post-proximal | 1 |
| 221 | post-right | 1 |
| 222 | postezetimibe | 1 |
| 223 | postmethionine | 1 |
| 224 | postsuckling | 1 |
| 225 | ppd-stimulated | 6 |
| 226 | pratsiol-associated | 1 |
| 227 | pre-/post-apheresis | 2 |
| 228 | pre-gh | 1 |
| 229 | preapheresis | 17 |
| 230 | ps-f2-stimulated | 1 |
| 231 | psg-1-indcued | 1 |
| 232 | ptnps-catalyzed | 1 |
| 233 | ptx3-neonatal | 1 |
| 234 | pyrazolocarbazole | 1 |
| 235 | quinine.a | 1 |
| 236 | ratio-iga-serum | 1 |
| 237 | retrospectively.in | 1 |
| 238 | rh- | 1 |
| 239 | rituximab-induced | 1 |
| 240 | rns-related | 1 |
| 241 | rotaglide+ | 3 |
| 242 | s-carboxy-methylated | 1 |
| 243 | sagrat | 1 |
| 244 | sall4/sox2/oct-3/4 | 1 |
| 245 | segfr-dependent | 2 |
| 246 | self-efficacy.a | 1 |
| 247 | serum | 46,955 |
| 248 | serum-ascites | 1 |
| 249 | serum-screening | 1 |
| 250 | serum/adipose | 1 |
| 251 | serum/dietary | 3 |
| 252 | serum/hepatic | 3 |
| 253 | situation.- | 1 |
| 254 | slow-cooled | 2 |
| 255 | sphingolipid-derived | 1 |
| 256 | str/log | 1 |
| 257 | suhexiang | 2 |
| 258 | t4-off | 2 |
| 259 | terpenylated | 1 |
| 260 | tetra-sodium | 1 |
| 261 | tg/low | 2 |
| 262 | tgf-β1-treated | 1 |
| 263 | three-hundred-fifty-four | 1 |
| 264 | time-zero | 1 |
| 265 | toluenesulfonamide | 1 |
| 266 | transcardiac | 10 |
| 267 | transcranial-evoked | 1 |
| 268 | treatment-by-serum | 1 |
| 269 | triglyceride-low | 2 |
| 270 | triglyceride/low | 3 |
| 271 | tumour-produced | 1 |
| 272 | uncarboxylated | 19 |
| 273 | unrestrains | 1 |
| 274 | vitro-stimulated | 1 |
| 275 | vldl-associated | 5 |
| 276 | xieqing | 1 |
| 277 | zakhire | 1 |
| 278 | zakhireh-i | 1 |
| 279 | zuoci | 1 |
| 280 | µmol/mmol | 1 |
| 281 | α-2,3-bound | 1 |
| 282 | α-oligoglucosyl | 2 |
| 283 | α9-subunit-containing | 1 |
| 284 | β-2,5-furanoid | 1 |
| 285 | δfree | 2 |
| 286 | δhr/δlog | 1 |
| 287 | δserum | 2 |
| 288 | ∆total | 2 |
| 1 | rotaglide+ | 3 |
| 2 | situation.- | 1 |
| 3 | ef-cm-f1- | 1 |
| 4 | cd31+cd42- | 1 |
| 5 | rh- | 1 |
| 6 | ng-monomethyl- | 1 |
| 7 | avidin- | 1 |
| 8 | cobalt- | 1 |
| 9 | density- | 1 |
| 10 | pai-1/ | 1 |
| 11 | ldl-c/ | 3 |
| 12 | l-citrulline/ | 1 |
| 13 | hdl-paf-ah/ | 2 |
| 14 | cholesterol/ | 5 |
| 15 | calcium/ | 3 |
| 16 | lecithin/ | 1 |
| 17 | amoxicillin/ | 7 |
| 18 | 6,210 | 1 |
| 19 | 4,540 | 1 |
| 20 | 6141 | 1 |
| 21 | 18,491 | 1 |
| 22 | limit-2 | 2 |
| 23 | 14122 | 1 |
| 24 | 9,072 | 1 |
| 25 | 11,443 | 2 |
| 26 | sall4/sox2/oct-3/4 | 1 |
| 27 | 20,224 | 1 |
| 28 | 2,052,534 | 1 |
| 29 | 40,544 | 1 |
| 30 | c3hc4 | 1 |
| 31 | hamd-5 | 1 |
| 32 | 4915 | 1 |
| 33 | 10306 | 1 |
| 34 | 2,2-2,7 | 1 |
| 35 | 6,618,637 | 1 |
| 36 | isrctn42521357 | 1 |
| 37 | 12/368 | 1 |
| 38 | 2010.a | 1 |
| 39 | levobupivicaine.a | 1 |
| 40 | quinine.a | 1 |
| 41 | children.a | 1 |
| 42 | self-efficacy.a | 1 |
| 43 | 67-kda | 1 |
| 44 | kokkola | 1 |
| 45 | dialysate-plasma | 4 |
| 46 | pl-plasma | 2 |
| 47 | dialysate-to-plasma | 7 |
| 48 | dialysis-to-plasma | 1 |
| 49 | amerlex-mab | 9 |
| 50 | 400-ppb | 3 |
| 51 | non-ldl-c | 2 |
| 52 | transcardiac | 10 |
| 53 | alpha-myhc | 1 |
| 54 | gm1-specific | 2 |
| 55 | pa-specific | 2 |
| 56 | papa-specific | 1 |
| 57 | caf-specific | 2 |
| 58 | emblic | 4 |
| 59 | non-allylic | 1 |
| 60 | antioncogenic | 1 |
| 61 | belleric | 1 |
| 62 | hyper-uric | 1 |
| 63 | blood/uric | 1 |
| 64 | serum/hepatic | 3 |
| 65 | non-phytic | 1 |
| 66 | mrc/eortc | 2 |
| 67 | madrs/ham-d | 1 |
| 68 | c24:1-induced | 1 |
| 69 | rituximab-induced | 1 |
| 70 | nonenzymatic-induced | 1 |
| 71 | il-3/tnf-induced | 1 |
| 72 | milking-induced | 4 |
| 73 | mtbs-induced | 1 |
| 74 | male-noninduced | 1 |
| 75 | tumour-produced | 1 |
| 76 | cysteine-enriched | 1 |
| 77 | ischaemia-modified | 2 |
| 78 | ischemia-modified | 9 |
| 79 | crp-stratified | 2 |
| 80 | immunization-linked | 1 |
| 81 | cse-evoked | 2 |
| 82 | transcranial-evoked | 1 |
| 83 | iodine-labeled | 1 |
| 84 | slow-cooled | 2 |
| 85 | dxa-determined | 1 |
| 86 | aluminum-co-doped | 1 |
| 87 | benzylamine-based | 1 |
| 88 | gel-released | 1 |
| 89 | creatinine-normalised | 1 |
| 90 | tgf-β1-treated | 1 |
| 91 | macroaggregated | 3 |
| 92 | plasma-conjugated | 2 |
| 93 | polysulphated | 1 |
| 94 | asparaginase-associated | 1 |
| 95 | vldl-associated | 5 |
| 96 | pratsiol-associated | 1 |
| 97 | non-ribavirin-associated | 1 |
| 98 | pin1-mediated | 1 |
| 99 | folate-mediated | 1 |
| 100 | lectin-related | 1 |
| 101 | bipolar-related | 4 |
| 102 | rns-related | 1 |
| 103 | friedewald-calculated | 2 |
| 104 | ps-f2-stimulated | 1 |
| 105 | bde-47-stimulated | 1 |
| 106 | oa-stimulated | 1 |
| 107 | ppd-stimulated | 6 |
| 108 | desipramine-stimulated | 1 |
| 109 | peak-stimulated | 6 |
| 110 | vitro-stimulated | 1 |
| 111 | s-carboxy-methylated | 1 |
| 112 | terpenylated | 1 |
| 113 | homocysteinylated | 1 |
| 114 | uncarboxylated | 19 |
| 115 | hpl-coated | 1 |
| 116 | dehydration/elevated | 1 |
| 117 | lipid-corrected | 2 |
| 118 | dipeptide-supplemented | 7 |
| 119 | log-adjusted | 1 |
| 120 | medication-adjusted | 1 |
| 121 | psg-1-indcued | 1 |
| 122 | sphingolipid-derived | 1 |
| 123 | glycerophospholipid-derived | 1 |
| 124 | nk-derived | 1 |
| 125 | gp-derived | 1 |
| 126 | cationized | 1 |
| 127 | ptnps-catalyzed | 1 |
| 128 | β-2,5-furanoid | 1 |
| 129 | follicular-fluid | 3 |
| 130 | direct/and | 2 |
| 131 | α-2,3-bound | 1 |
| 132 | phytate-bound | 1 |
| 133 | lectin-bound | 2 |
| 134 | bldod | 1 |
| 135 | postezetimibe | 1 |
| 136 | kemtrace | 2 |
| 137 | nematocide | 1 |
| 138 | toluenesulfonamide | 1 |
| 139 | dialysate-side | 2 |
| 140 | baseline-free | 1 |
| 141 | acyl/free | 1 |
| 142 | δfree | 2 |
| 143 | membrane/storage | 1 |
| 144 | an1/a20-like | 1 |
| 145 | a20/an1-like | 1 |
| 146 | faah-like | 1 |
| 147 | cll-like | 1 |
| 148 | pgi-memory-scale | 1 |
| 149 | goal/desirable | 2 |
| 150 | non-hydrolysable | 1 |
| 151 | 'undetectable | 1 |
| 152 | bio-accessible | 3 |
| 153 | plasma-soluble | 3 |
| 154 | per-follicle | 1 |
| 155 | 1-tertile | 1 |
| 156 | pyrazolocarbazole | 1 |
| 157 | postmethionine | 1 |
| 158 | kidney-urine | 1 |
| 159 | polyglecaprone | 1 |
| 160 | hepatic-borne | 1 |
| 161 | zakhire | 1 |
| 162 | late-follicular-phase | 3 |
| 163 | before-exercise | 1 |
| 164 | pentulose | 6 |
| 165 | serum/adipose | 1 |
| 166 | anti-merozoite | 2 |
| 167 | neuroinhibitory/neuroprotective | 1 |
| 168 | t4-off | 2 |
| 169 | dnnrsf | 7 |
| 170 | :3xflag | 1 |
| 171 | 0.75-mg/kg | 1 |
| 172 | microm/mg | 2 |
| 173 | suhexiang | 2 |
| 174 | an-gong-niu-huang | 3 |
| 175 | postsuckling | 1 |
| 176 | serum-screening | 1 |
| 177 | apoa-i-containing | 2 |
| 178 | neodymium-containing | 1 |
| 179 | α9-subunit-containing | 1 |
| 180 | xieqing | 1 |
| 181 | lipid-transporting | 1 |
| 182 | str/log | 1 |
| 183 | δhr/δlog | 1 |
| 184 | mau*min/μg | 1 |
| 185 | pre-gh | 1 |
| 186 | hdl/high | 10 |
| 187 | hdl-cholesterol/high | 1 |
| 188 | hdl-c±high | 1 |
| 189 | zakhireh-i | 1 |
| 190 | zuoci | 1 |
| 191 | anti-bcii | 1 |
| 192 | microsemi | 6 |
| 193 | huoxiangzhengqi | 1 |
| 194 | micheal | 1 |
| 195 | post-proximal | 1 |
| 196 | goal/normal | 6 |
| 197 | ardenal | 1 |
| 198 | baculoviral | 3 |
| 199 | ptx3-neonatal | 1 |
| 200 | mg/total | 6 |
| 201 | lpa-i/total | 1 |
| 202 | ∆total | 2 |
| 203 | peri-conceptual | 1 |
| 204 | hemosil | 2 |
| 205 | pg/mmol | 1 |
| 206 | µmol/mmol | 1 |
| 207 | hexaacyl | 1 |
| 208 | lysophosphatidyl | 1 |
| 209 | 2,2,4,4-d4-diethyl | 1 |
| 210 | 1,1,1,5,5,5-d6-diethyl | 1 |
| 211 | n-monomethyl | 1 |
| 212 | n-alpha-tosyl-l-lysyl-chloromethyl | 1 |
| 213 | 4-methacryloyloxyethyl | 1 |
| 214 | 1,1',2,2'-tetramyristoyl | 1 |
| 215 | myristamidopropyl | 2 |
| 216 | isovaleryl | 1 |
| 217 | diphosphoryl | 1 |
| 218 | monophosphoryl | 15 |
| 219 | α-oligoglucosyl | 2 |
| 220 | hydroxylysyl | 1 |
| 221 | phnom | 7 |
| 222 | aapm | 2 |
| 223 | tetra-sodium | 1 |
| 224 | n-benzoylimino-3,4-dihydro-6-methylisoquinolinium | 1 |
| 225 | serum | 46,955 |
| 226 | *serum | 1 |
| 227 | ratio-iga-serum | 1 |
| 228 | low-serum | 3 |
| 229 | treatment-by-serum | 1 |
| 230 | 1/serum | 3 |
| 231 | plasma/serum | 16 |
| 232 | lic/serum | 1 |
| 233 | δserum | 2 |
| 234 | biman | 1 |
| 235 | oxldl/human | 2 |
| 236 | neutropenia.when | 1 |
| 237 | retrospectively.in | 1 |
| 238 | h-chain | 2 |
| 239 | changesin | 1 |
| 240 | on-statin | 10 |
| 241 | phytin | 2 |
| 242 | buhlmann | 1 |
| 243 | /admission | 1 |
| 244 | post-anticoagulation | 1 |
| 245 | gianturco | 1 |
| 246 | time-zero | 1 |
| 247 | nt-pro | 32 |
| 248 | anti-als3p | 1 |
| 249 | intramyocellular | 58 |
| 250 | heme-scavenger | 1 |
| 251 | inner-to-outer | 1 |
| 252 | three-hundred-fifty-four | 1 |
| 253 | serum-ascites | 1 |
| 254 | high-hs | 1 |
| 255 | cys3his | 1 |
| 256 | pre-/post-apheresis | 2 |
| 257 | preapheresis | 17 |
| 258 | unrestrains | 1 |
| 259 | c5-sugars | 1 |
| 260 | hairpinless | 2 |
| 261 | phosphatase-minus | 1 |
| 262 | sagrat | 1 |
| 263 | end-of-diet | 1 |
| 264 | intraplatelet | 22 |
| 265 | post-right | 1 |
| 266 | depression-infant | 1 |
| 267 | myrosinase-dependent | 1 |
| 268 | segfr-dependent | 2 |
| 269 | fxr-dependent | 1 |
| 270 | carbohydrate-deficient | 21 |
| 271 | triglyceride-low | 2 |
| 272 | igf1/low | 1 |
| 273 | il-17/low | 1 |
| 274 | triglyceride/low | 3 |
| 275 | tg/low | 2 |
| 276 | htg/low | 4 |
| 277 | b-box | 1 |
| 278 | plasma/urinary | 1 |
| 279 | collagen/urinary | 1 |
| 280 | serum/dietary | 3 |
| 281 | intrapituitary | 3 |
| 282 | m-hydroxy-p-methoxy | 1 |
| 283 | 3,4-dimethoxy | 2 |
| 284 | -epoxy | 1 |
| 285 | 1-alpha-hydroxy | 1 |
| 286 | mothers | 1 |
| 287 | floraglo® | 1 |
| 288 | elecsys® | 3 |